Onyx Biotec Limited (NSEI: ONYX)
Health Care · Pharmaceuticals · IN
Rs38.00
+1.20% today · -12.3% 1Y
Onyx Biotec Limited (NSEI: ONYX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $7.12M.
Over the last twelve months the share price has lost 12.3%, trading between 24.20 and 49.65.
Tweenvest scores Onyx Biotec Limited across four factors: quality 60/100, value 39/100. Its strongest factor is quality.
ONYX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.12M
- Revenue (TTM)
- $7.41M
- P/E
- —
- EPS
- -0.12
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs49.65
- 52-week low
- Rs24.20
- Avg volume (3M)
- —
- Shares outstanding
- 18.13M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vineet Laboratories LimitedNSEI: VINEETLAB | $7.43M | Rs37.45 | +4.29% |
| Pila Pharma AB (publ)OM: PILA | $7.38M | Skr1.70 | +5.26% |
| Incanthera plcOFEX: INC | $7.33M | £0.04 | -10.98% |
| Zenith Drugs LimitedNSEI: ZENITHDRUG | $7.19M | Rs40.60 | -3.45% |
| Cann Group LimitedASX: CAN | $6.95M | AU$0.01 | +33.33% |
| Traws Pharma, Inc.NasdaqCM: TRAW | $6.84M | $0.42 | -6.78% |
| Epsilon Healthcare LimitedASX: EPN | $6.79M | AU$0.03 | -3.85% |
| Newbury Pharmaceuticals AB (publ)OM: NEWBRY | $6.72M | Skr2.20 | -0.45% |
Figures last refreshed Oct 11, 2026.